Annals of Surgical Oncology

, Volume 18, Supplement 3, pp 187–188 | Cite as

Neoadjuvant Intraperitoneal and Systemic Chemotherapy for Gastric Cancer Patients with Peritoneal Dissemination

Gastrointestinal Oncology

Keywords

Gastric Cancer Systemic Chemotherapy Gastric Cancer Patient Peritoneal Metastasis Peritoneal Dissemination 

References

  1. 1.
    Fujiwara Y, Takiguchi S, Nakajima K, Miyata H, Yamasaki M, Kurokawa Y, Okada K, Mori M, Doki Y. Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination. Ann Surg Oncol. 2011;17:1770–8.Google Scholar
  2. 2.
    Fujiwara Y, Nishida T, Takiguchi S, Nakajima K, Miyata H, Yamasaki M, Yamamoto K, Moon JH, Mori M, Doki Y. Feasibility study of S-1 and intraperitoneal docetaxel combination chemotherapy for gastric cancer with peritoneal dissemination. Anticancer Res. 2010;30:1335–9.PubMedGoogle Scholar
  3. 3.
    Ishigami H, Kitayama J, Kaisaki S, Hidemura A, Kato M, Otani K, Kamei T, Soma D, Miyato H, Yamashita H, Nagawa H. Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis. Ann Oncol. 2010;21:67–70.PubMedCrossRefGoogle Scholar
  4. 4.
    Okabe H, Ueda S, Obama K, Hosogi H, Sakai Y. Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination. Ann Surg Oncol. 2009;16:3227–36.PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2011

Authors and Affiliations

  1. 1.Department of SurgeryMedical Center for Cancer and Cardiovascular DiseasesOsaka CityJapan

Personalised recommendations